🇺🇸 FDA
Patent

US 9670141

(S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

granted A61KA61K31/196A61P

Quick answer

US patent 9670141 ((S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma) held by Northwestern University expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/196, A61P, A61P25/00, A61P25/04